170 related articles for article (PubMed ID: 21175543)
1. Platelet function, activation and apoptosis during and after apheresis.
Bakry R; Sayed D; Galal H; Shaker S
Ther Apher Dial; 2010 Oct; 14(5):457-64. PubMed ID: 21175543
[TBL] [Abstract][Full Text] [Related]
2. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
Procházková R; Andrýs C; Hubácková L; Krejsek J
Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
[TBL] [Abstract][Full Text] [Related]
3. Platelet function testing during 5-day storage of single and random donor plateletpheresis.
Akay OM; Gündüz E; Başyiğit H; Gulbas Z
Transfus Apher Sci; 2007 Jun; 36(3):285-9. PubMed ID: 17602871
[TBL] [Abstract][Full Text] [Related]
4. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
5. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
Ali SF
Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
[TBL] [Abstract][Full Text] [Related]
6. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
[TBL] [Abstract][Full Text] [Related]
7. Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?
Sener A; Ozsavci D; Oba R; Demirel GY; Uras F; Yardimci KT
Clin Biochem; 2005 Dec; 38(12):1081-7. PubMed ID: 16253220
[TBL] [Abstract][Full Text] [Related]
8. The combined effect of platelet storage media and intercept pathogen reduction technology on platelet activation/activability and cellular apoptosis/necrosis: Lisbon-RBS experience.
Carvalho H; Alguero C; Santos M; de Sousa G; Trindade H; Seghatchian J
Transfus Apher Sci; 2006 Apr; 34(2):187-92. PubMed ID: 16574488
[TBL] [Abstract][Full Text] [Related]
9. Enhanced platelet responsiveness due to chilling and its relation to CD40 ligand level and platelet-leukocyte aggregate formation.
Ayukawa O; Nakamura K; Kariyazono H; Ikeda R; Arima J; Shinkawa T; Iwase H; Sakata R; Yamada K
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):176-84. PubMed ID: 19300046
[TBL] [Abstract][Full Text] [Related]
10. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.
Zeiler T; Gritzka D; Karger R; Kretschmer V
Transfusion; 2004 Sep; 44(9):1300-5. PubMed ID: 15318852
[TBL] [Abstract][Full Text] [Related]
11. L-carnitine improves pH and decreases surface phosphatidylserine expression in extended stored apheresis platelets.
Sweeney JD; Kouttab NM; Arduini A
J Clin Apher; 2004; 19(2):98-102. PubMed ID: 15274203
[TBL] [Abstract][Full Text] [Related]
12. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
[TBL] [Abstract][Full Text] [Related]
13. Impact of tobacco smoking on platelet function in apheresis products in vitro.
Scheinichen D; Heuft HG; Renken C; Jüttner B; Jaeger K; Schürholz T; Blasczyk R; Piepenbrock S; Elsner HA
Vox Sang; 2004 May; 86(4):252-6. PubMed ID: 15144530
[TBL] [Abstract][Full Text] [Related]
14. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
15. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies.
Picker SM; Schneider V; Gathof BS
Transfusion; 2009 Jun; 49(6):1224-32. PubMed ID: 19220821
[TBL] [Abstract][Full Text] [Related]
16. Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system.
Palmer DS; Aye MT; Dumont L; Dumont D; McCombie N; Giulivi A; Rutherford B; Trudel E; Hashemi-Tavoularis S
Vox Sang; 1998; 75(2):115-23. PubMed ID: 9784664
[TBL] [Abstract][Full Text] [Related]
17. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
Albanyan AM; Murphy MF; Rasmussen JT; Heegaard CW; Harrison P
Transfusion; 2009 Jan; 49(1):99-107. PubMed ID: 18954406
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Impact-R for monitoring the platelet storage lesion.
Albanyan AM; Murphy MF; Harrison P
Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
[TBL] [Abstract][Full Text] [Related]
19. Platelet function under high-shear conditions from platelet concentrates.
Jilma-Stohlawetz P; Horvath M; Eichelberger B; Koren D; Jilma B; Panzer S
Transfusion; 2008 Jan; 48(1):129-35. PubMed ID: 17894788
[TBL] [Abstract][Full Text] [Related]
20. Detection of activated platelets in canine blood by use of flow cytometry.
Wills TB; Wardrop KJ; Meyers KM
Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
